Possible risk of autism in children. Dormant cancer cells awakening. Accelerating aging of the brain. Federal officials in May 2023 declared an end to the national covid pandemic. But more than two years later, a growing body of research continues to reveal information about the virus and its ability to cause harm long after initial…
AstraZeneca’s equity investment in Summit Therapeutics comes with plans for clinical trial collaborations. The deal brings AstraZeneca into a growing group of pharmaceutical companies testing the pairing of antibody drug conjugates with PD-1/VEGF bispecific antibodies, a drug combination that could offer advantages in cancer treatment. The post AstraZeneca Places a $2B Bet on a Summit…
At Wednesday’s keynote address for HIMSS25, General Nakasone discussed disruptive technologies
Changing any status quo is challenging, but maintaining the status quo of low patient literacy in healthcare is costly and detrimental to both patients and healthcare organizations. Investing in patient literacy is therefore investing in healthcare itself. The post Oncology Nurses Are Key to Patient Literacy But They Need Support appeared first on MedCity News.
Even top companies struggle to maintain adequate IT staffing levels. Here are several reasons why FQHCs should consider outsourcing to a firm experienced in the nuances of healthcare. The post Why Outsourcing IT and Cybersecurity is the Smart Choice for FQHCs appeared first on MedCity News.
This issue brief presents findings from the focus groups including caregiver characteristics; physical, emotional, and mental caregiving demands of caregiving; their wages, finances, and opportunities for advancement; and what caregivers would like policymakers to know about their work.
“When you cut one part of the health system, it tends to have a ripple effect on the rest of it,” an expert notes at Webinar
During a panel discussion at HLTH, Chelsea Clinton shared three things she wants healthcare leaders to know going into the election when it comes to reproductive health. The post Chelsea Clinton on Reproductive Rights: 3 Things to Know appeared first on MedCity News.
By KIM BELLARD I know: you’re pretty proud for being into “wearables” to help monitor your health and other functions. You’ve got some apps on your smartphone. You use a smartwatch. Maybe you’ve tried one of the many iterations of smart glasses, like Google Glass or Meta’s Ray Bans. You were disappointed when Humane’s AI…
A planned interim clinical trial analysis found Praxis Precision Medicines drug ulixacaltamide was unlikely to succeed as a treatment for essential tremor. But Praxis is continuing two late-stage tests of the drug; data are expected in the third quarter of 2025. The post Praxis Presses Forward in Essential Tremor Despite Futility Finding From Trial Observers…